Login
Home / OPHLY : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ono Pharmaceutical Co., Ltd.

$5 +$0.45 (+9.89%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$4.96
Day Range
$4.99$5.03
Year Range
$3.71$5.75
Market Cap
7.05B
AVG Volume
38.79K
Trailing/Forward PE
14.32/0.1
PEG ratio
-1.26
Dividend Yield
3.44%
Next Earnings Date
2026-11-02
Primary Exchange
Other OTCUS
Revenue (JPY)
050B100B150B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Net Income (JPY)
-10B010B20B30B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Operating Income (JPY)
-20B020B40B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EBITDA (JPY)
-20B020B40B60B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash Flows (JPY)
-20B020B40B60B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EPS (JPY)
-10010203024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Expenses (JPY)
020B40B60B80BR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash & Debt (JPY)
0100B200B300BCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Debt ratios
-1.5-1-0.500.524 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Margins
0%20%40%60%80%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Return on Capital
-2%0%2%4%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Shares Outstanding
02B4B6B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Dividends (JPY)
00.030.050.080.1Mar 22Sep 22Mar 23Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Sep 26
Book Value Per Share (JPY)
020040060080024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Total Assets (JPY)
0500B1T1.5T24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
PE Ratio
51015202530med 15.84Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
6%8%10%12%14%16%med 9.93%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
11.522.5med 1.73Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
2.557.51012.515med 8.1Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
510152025med 11.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.811.21.41.6med 1.1Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Ono Pharmaceutical Co., Ltd.
OPHLY
Stockpicker

Video analysis: OPHLY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: OPHLY

Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases

businesswire.com · 1 Sep 2026

Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced that it has entered into a drug discovery partnership agreement with Aitia, Inc. (Headquarters: Cambridge, Massachusetts, USA; CEO: Colin Hill; “Aitia”). Under the terms of the agreement, Aitia will utilize its REFS™ technology to build Gemini Digital Twins (GDTs) of neurological diseases and identify new therapeutic targets and bio.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.